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ABSTRACT Candida albicans is the most prevalent fungal pathogen of humans, causing a variety of diseases ranging from super-
ficial mucosal infections to deep-seated systemic invasions. Mucus, the gel that coats all wet epithelial surfaces, accommodates
C. albicans as part of the normal microbiota, where C. albicans resides asymptomatically in healthy humans. Through a series of
in vitro experiments combined with gene expression analysis, we show that mucin biopolymers, the main gel-forming constitu-
ents of mucus, induce a new oval-shaped morphology in C. albicans in which a range of genes related to adhesion, filamentation,
and biofilm formation are downregulated. We also show that corresponding traits are suppressed, rendering C. albicans im-
paired in forming biofilms on a range of different synthetic surfaces and human epithelial cells. Our data suggest that mucins
can manipulate C. albicans physiology, and we hypothesize that they are key environmental signals for retaining C. albicans in
the host-compatible, commensal state.
IMPORTANCE The yeast Candida albicans causes both superficial infections of the mucosa and life-threatening infections upon
entering the bloodstream. However, C. albicans is not always harmful and can exist as part of the normal microbiota without
causing disease. Internal body surfaces that are susceptible to infection by C. albicans are coated with mucus, which we hypothe-
size plays an important role in preventing infections. Here, we show that the main components of mucus, mucin glycoproteins,
suppress virulence attributes of C. albicans at the levels of gene expression and the corresponding morphological traits. Specifi-
cally, mucins suppress attachment to plastic surfaces and human cells, the transition to cell-penetrating hyphae, and the forma-
tion of biofilms (drug-resistant microbial communities). Additionally, exposure to mucins induces an elongated morphology
that physically resembles the mating-competent opaque state but is phenotypically distinct. We suggest that mucins are potent
antivirulence molecules that have therapeutic potential for suppressing C. albicans infections.
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Candida albicans is an important opportunistic fungal patho-gen in humans that can cause superficial infections, such as
vaginitis in women or thrush in babies and HIV patients, and
systemic, often fatal, disease in more advanced cases (1). C. albi-
cans possesses a range of virulence traits, including adherence,
filamentation, and secretion of proteases (2). At the heart of many
infections is the formation of surface-associated C. albicans com-
munities, also termed biofilms, which can form on mucosal epi-
thelial surfaces and on implanted medical devices, such as cathe-
ters and heart valves. Biofilms show increased resistance both to
the immune system and to antifungal treatment (3). Despite the
ability of C. albicans to cause disease, the healthy human body
accommodates it as part of the microbiota (4–6). How the body
tolerates the continued presence of potentially virulentC. albicans
is largely unknown.
Mucus is the slimy coating found on all wet epithelia in the
human body, including the eyes, airways, and the gastrointestinal
and female genitourinary tracts, and many host-microbe interac-
tions take place in this context. Its major gel-forming compo-
nents, the mucin glycopolymers, are emerging as important regu-
lators ofmicrobial virulence. For example, the human cell-surface
mucin MUC1 can inhibit surface adhesion of the gastric bacte-
riumHelicobacter pylori (7).Moreover, the secreted humanmucin
Muc5AC can prevent Pseudomonas aeruginosa surface attachment
and biofilm formation by promoting a dispersive state of bacteria
(8). Other examples include mucus-mediated clearance of the
bacterium Streptococcus pneumoniae (9) and modulation of
HIV-1 (10) and influenza virus (11) infectivity by mucins. These
observations indicate that mucin biopolymers help prevent bac-
terial and viral infections by regulating cellular processes related to
virulence. Fungal pathogens are only distantly related to bacteria
and viruses, and little is known about their interactions with mu-
cins.
Here, we investigate the role of mucins as potential regulators
of C. albicans virulence. Using a combination of gene expression
analysis, mucus-secreting cell lines, and defined in vitro assays
with natively purified mucins, we show that exposure to mucins
induces a new oval-shaped morphological state in C. albicans in
which various virulence traits are downregulated, including sur-
face adhesion, the morphological transition to the filamentous
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state, and biofilm formation. Our results indicate that mucins are
key contributors to host defense against C. albicans and may offer
new strategies to target fungal virulence, such as the design of
antifungal treatments or coatings for implants.
RESULTS
Mucins regulateC. albicans physiology.To determine the effects
of mucins on C. albicans, the strain SC5314 was cultured in RPMI
medium with and without pig gastric mucins (Muc5AC); RPMI
favors growth in the filamentous state. Mucins were supple-
mented in themedium to create a 3-dimensional environment, as
is found in the native mucus barrier (8). In the absence of mucins,
the cells formed extensive hyphae which clumped together into
flocs (Fig. 1A). In contrast, mucin-exposed cells predominantly
formed short chains resembling pseudohyphae (Fig. 1A) or uni-
cellular, ellipsoidal cells that are distinct from the round, yeast
form cells. An analysis of the growth rate of C. albicans in mucins
shows that cells continue to grow over time and even show an
enhanced increase in optical density (OD) due to the homogenous
suspension of individual cells as opposed to the filamentous flocs
formed in RPMI medium alone (see Fig. S1 in the supplemental
material).
Importantly, the effect ofMuc5AC onC. albicans physiology is
not limited to this type of mucin but was also observed for two
other mucins: Muc2 from pig intestinal mucus and Muc5B from
human saliva (Fig. 1B). This indicates that mucins have a general
effect onC. albicans that likely extends across all mucosal surfaces.
Due to the abundant availability ofMuc5AC, the remainder of the
experiments in this study were performed using this mucin.
At first sight, the mucin-induced morphology resembles
opaque cells, which are the mating competent form of C. albicans
(12) that have reduced virulence in systemic infection models
(13). Since the ability ofC. albicans to switch to the opaque state is
controlled by genes at themating type-like (MTL) locus, such that
only MTLa or MTL strains can undergo the transition to the
opaque form, we first tested whether mucins would induce our
starting MTLa/ heterozygous strains to become homozygous
MTLa orMTLmating-competent cells. Using PCRwith primers
specific to theMTL locus, we found that mucin-exposed cells re-
mained heterozygous at the MTL locus (n  100). To further
probe their identity, the mucin-exposed cells were assayed for
three features that are indicative of opaque cells: the abilities to
form opaque colonies on agar plates (14), mate in the presence of
the oppositemating type (15, 16), and formmating protrusions in
the presence of mating pheromone (17). Our data show that the
mucin-exposed cells were incapable of these three traits: they did
not form opaque colonies, were not mating competent, and did
not form mating protrusions in the presence of mating
-pheromone (see Table S1 in the supplemental material). More-
over, exposure ofwor1/ cells (which cannot form opaque cells)
to mucins also induced the oval-shaped morphology (Fig. S2),
suggesting that the mucin-dependent morphology can develop
independently of the master regulator of opaque status. As one
further control, we repeated the white-opaque switching, quanti-
tativemating, and pheromone response assays usingmating com-
petent MTLa or MTL cells and found that mucins do not affect
these opaque processes in mating competent strains (Table S1).
Taken together, these results indicate that exposure to mucins
suppresses the formation of hyphae while inducing the formation
of a novel phenotype that superficially resembles the opaque cell
type but is distinct in its physiological responses.
Mucins downregulate virulence-associated genes in C. albi-
cans. To better characterize the mucin-induced morphological
change, we carried out transcriptional profiling experiments. A
wild-typeC. albicans strain (SC5314)was grown for 8 h inRPMI at
37°C in the presence and absence of 0.5%mucins. We performed
quantitative PCR (qPCR) (Fig. 1C) to measure the expression
levels of selected virulence genes (listed in Table S2 in the supple-
mental material), including those associated with adhesion (18),
biofilm formation (19), and secreted proteinases (20). TAF145, a
general transcription factor TFIID subunit (21), did not change
expression in the presence of mucins and was used as a reference
for calibration. The results of this experiment show that 7 of the 16
genes tested (Fig. 1C, P values indicated by asterisks) were down-
regulated by more than 1.5-fold in the presence of mucins (P 
0.05) as determined by a two-tailed, unpaired t test comparing the
cycle threshold (CT) values of samples with andwithoutmucins.
Mucins suppress C. albicans transition to the filamentous
state. To understand in more detail the effect of mucins on C. al-
bicans physiology, we monitored the C. albicans strain HGFP3,
FIG 1 Mucins induce a unique morphological state characterized by sup-
pressed virulence traits. (A) Phase-contrast images of C. albicans in different
morphological states. (B) Phase-contrast images of C. albicans after growth in
the presence or absence (- Mucins) of one of the following mucins: pig gastric
(Muc5AC), pig intestinal (Muc2), or human salivary (Muc5B). (C) Results of
qPCR of known C. albicans virulence genes, comparing gene expression levels
in RPMI with mucins to their expression levels without mucins. RNA was
extracted from 6 independent biological replicates. Error bars represent stan-
dard errors of the means (SEM). Asterisks represent different P value thresh-
olds as follows: *, P 0.05; **, P 0.01; ***, P 0.001.
Kavanaugh et al.
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which expresses green fluorescent protein (GFP) when the
hyphal-specific gene HWP1 is transcribed, during growth in
RPMI with or without 0.5% natively purified mucins. To test
whether the effects are simply a response to an increased viscosity
or osmotic stress, we also subjected the cells to 0.5% industrially
purified mucins (Sigma-Aldrich), 0.5% methylcellulose, or 1 M
sorbitol. Industrially purifiedmucins are proteolytically processed
and, as a result, have lost the gel-forming capacity characteristic of
native mucins (22, 23). The polysaccharide methylcellulose is
commonly used to mimic the viscosity of a mucus environment
(24, 25). Sorbitol at high concentrations can induce osmotic
stress; testing this condition is informative because the osmotic
stress pathway is linked to hyphal formation (26). Our data show
that in the no-polymer control, as well as in the presence of meth-
ylcellulose or 1M sorbitol, the majority of cells formed hyphae, as
indicated both by the elongated structures and the presence of
GFPfluorescence (Fig. 2A, left; see also Fig. S3A in the supplemen-
tal material). In contrast, in the presence of native mucins, hyphal
formation was nearly completely suppressed. Industrial mucins
also inhibited hyphal formation, although not as effectively as the
native mucins; a proportion of cells remained in the hyphal form.
These results suggest that specific biochemical attributes present
in the mucins suppress hyphal formation. Natively purified mu-
cins are obtained by a relatively mild purification procedure to
preserve their structure, and it is formally possible that contami-
nants contribute to the regulation of theC. albicans phenotype. To
exclude this possibility, we also tested mucins purified with CsCl,
a more stringent condition which removes the majority of associ-
ated proteins and lipids from the mucins. We observed the same
suppression of hyphal formation as in the presence of natively
purified mucins (Fig. S4), indicating that this effect is due to the
mucins and not to any associated factors.
The ability of mucins to suppress filamentation was also stud-
ied at the level of gene expression. Using qPCR, we analyzed the
expression levels of the hypha-specific genes ALS3, ECE-1, and
HWP1 under four medium conditions: medium without poly-
mers and with native mucins, industrial mucins, and methylcel-
lulose. For all three genes, native mucins mediated the strongest
downregulation (Fig. 2B). Of note is that this mucin-induced
downregulation of hypha-specific genes was also observed in an
alternative culture medium, yeast extract-peptone-dextrose
(YPD) plus fetal bovine serum (FBS) (see Fig. S5 in the supple-
mental material), indicating that the effects of mucins are not
dependent on a specific medium condition.
We next tested the effects of mucins on preformed hyphae.
Hyphae formed in the absence of mucins were inoculated into
RPMI with and without 0.5% mucins or 0.5% methylcellulose.
Our data show that newly formed cells, which bud off from the
hyphae, were predominantly in the yeast form after exposure to
mucins (Fig. 2A, right). In comparison, hyphae in the absence of
mucins continued to produce hyphae. Hyphal cells inoculated
into medium containing methylcellulose also continued to pro-
duce more hyphal cells. These results were verified by qPCR,
which showed that native mucins have the strongest capacity to
suppress hyphal formation (Fig. 2C). We note that the levels of
expression of the gene HWP1 showed a lower degree of suppres-
sion (yet still significant; P  0.001) when hyphae were added as
the starting culture than when yeast cells were added (1.3-fold
change in expression with hyphal inoculum versus 15.9-fold
change for yeast). Thus, in addition to inhibiting the growth of
hyphae in yeast form cells, we can also conclude that the hypha-
suppressive capacity of mucins is strong enough to downregulate
the responsible pathway in existing hyphae.
Mucins suppress surface adhesion of C. albicans A critical,
early step of infection by C. albicans is its attachment to a solid
surface. From the results shown in Fig. 1C, we observed that genes
involved in cell adhesion (ALS1 andALS3) were downregulated in
the presence of mucins. Moreover, we know that mucins may
physically trap certain particles and cells, thereby preventing their
association with an underlying surface. Hence, we tested whether
mediumcontaining gel-formingmucins also decreases the surface
attachment ofC. albicans. We analyzed the ability ofC. albicans to
colonize two different surfaces in the presence of mucins: abiotic
polystyrene, which is often used in the context of biofilm forma-
tion assays, and human epithelial mucus-secreting cells. For ad-
hesion to polystyrene, a suspension of yeast cells was inoculated
into polystyrene 96-well plates containing RPMI without or with
0.5% native mucins, industrially purified mucins, or methylcellu-
lose. The phase-contrast microscopy images and quantification
results in Fig. 3A and B show that native mucins significantly
reduced cell attachment to polystyrene. This effect was detectable
as early as 30min and became stronger over the course of the hour
(unpaired two-tailed t test; P  0.05). Methylcellulose was simi-
larly effective in suppressing cell surface attachment (Fig. 3A). For
comparison, industrially purified mucins provided no significant
protection from surface attachment. Native mucins and methyl-
cellulose both increase the viscosity of the medium, and hence,
this parameter could be responsible for the observed antiadhesion
effect. To test this, we subjected the yeast to medium containing
0.5% polyethylene glycol (PEG), which is often used as an anti-
fouling coating (27). Our data show that PEG was not able to
decrease surface attachment to the same degree as mucins and
methylcellulose (see Fig. S3B in the supplemental material), sug-
FIG 2 Mucins suppress hyphal growth from both yeast and hyphal cells.
Fluorescence microscopy images overlaid on phase-contrast images (A) and
quantitative PCR of the expression of hyphal-specific genes from yeast (B) or
hyphae (C) after incubation for 8 h in RPMI alone or with 0.5% methylcellu-
lose, 0.5% native mucins, or 0.5% industrially purified mucins. The strain
used, HGFP3, expresses GFP only when cells are true hyphae. RNA was ex-
tracted from 6 independent biological replicates. Error bars represent SEM.
Mucins Suppress Virulence of Candida albicans
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gesting that increased viscosity alone is not sufficient to protect a
surface from C. albicans attachment.
We next infected humanmucus-secreting cells withC. albicans
to determine the effects of mucus on attachment to a living sur-
face. C. albicans typically resides in the intestine as a commensal,
but this environment can also be the starting point for systemic
dissemination (28). A simple in vitromodel for the study of C. al-
bicans interactions with mucus-coated epithelial cells of the intes-
tines makes use of HT29-MTX cells derived from human colorec-
tal adenocarcinoma cells, which secrete native-like mucus when
growing in culture (29). Themucus layer can be removed from the
secreting cells with N-acetylcysteine (NAC), allowing for a com-
parison of cell adhesion with and without nativemucus. To deter-
mine the effects of mucus on the attachment of C. albicans to
human mucus-secreting epithelial cells, a suspension of C. albi-
canswas exposed to cells thatwere linedwith an intactmucus layer
or to cells fromwhich themucus had been removed. After 2 h, the
unbound C. albicans cells were removed by washing the epithelial
cells with phosphate-buffered saline. The microscopy images and
data in Fig. 3C andD show that significantlymoreC. albicans cells
attached to the unprotected epithelial cells than to cells that had
been shielded with a layer of mucus. This suggests that the mucus
lining of epithelial cells provides an efficient protection against the
attachment of C. albicans.
Mucins decrease C. albicans biofilm formation. C. albicans
readily forms surface-attached biofilms on both abiotic and biotic
surfaces. Because biofilm formation relies on attachment, fila-
mentation, and cell-cell interactions (30, 31), we tested whether
mucins inhibit biofilm formation by C. albicans. We used a stan-
dard biofilm assay in which a polystyrene surface is immersed in a
yeast culture (in RPMI) to allow attachment of the cells and, after
90 min, washed to remove nonadherent cells. Then, the surface is
submerged in fresh, cell-free medium to follow the development
of the initially attached cells into a biofilm over 8, 24, and 48 h.We
performed this assay in the presence of native mucins and, for
comparison, with methylcellulose and industrial mucins.
To evaluate the effect of the individual polymers onC. albicans
surface attachment, we removed the supernatant after the time
points indicated above (8, 24, and 48 h) and analyzed the resulting
biofilms (Fig. 4). Surface attachment was visibly reduced in the
presence of native mucins and even more effectively prevented in
the presence of methylcellulose (Fig. 4A). Confocal xy and xz sec-
tions of the biofilms show that both the surface coverage (xy im-
ages) and thickness (xz scan) of the biofilm are reduced in the
presence of mucins (Fig. 4C). Moreover, a smaller percentage of
cells in the mucin-treated biofilms form hyphae within the thin
biofilms, confirming the previous observation from the experi-
ment whose results are shown in Fig. 2. Finally, quantification of
the biofilm biomass shows a significant reduction in the presence
of mucins (Fig. 4D). These data suggest that both mucins and
methylcellulose have the capacity to suppress, or destabilize, the
attachment of C. albicans to an underlying polystyrene surface
over a relatively long period of time. In an experiment whose
results are shown in Fig. S1 in the supplemental material, we
showed that the cells continued to grow strongly in the presence of
both mucins and methylcellulose, indicating that the reduced
number of attached cells is not due to toxicity of the polymers.
If cell proliferation is not suppressed by the polymers and, yet,
a reduction of biomass is observed on the surface, one would
expect that a significant proportion of the population has been
shifted to the supernatant. This could occur if cells are released
from the biofilm and continue to propagate in the planktonic
phase. Indeed, the results in Fig. 4E show that the supernatant
from biofilms in the presence of mucins or methylcellulose con-
tained higher numbers of cells than the supernatants from bio-
films growing without mucins. This experiment also reveals an-
other important point: in the presence ofmucins, the nonattached
cells are largely devoid of filaments and, therefore, presumably are
in the less invasive form (Fig. 4B). In contrast, the cells in the
supernatant of methylcellulose cultures were all highly filamen-
tous. Together, these data suggest that both mucins and methyl-
cellulose can suppress the formation and maturation of biofilms
by reducing attachment of the cells to an underlying surface, pos-
sibly by preventing stable maintenance of cells within the biofilm.
However, mucins have a distinct effect: they render nearly the
entire population devoid of filaments.
DISCUSSION
This work shows that the mucin Muc5AC, which is expressed in
the stomach and in the lungs, can induce the downregulation of
several virulence traits in C. albicans, both at the level of gene
expression and phenotype. These include the suppression of both
filamentous growth and the formation of surface-attached bio-
films. Studies with other types ofmucins (Fig. 1B) (32, 33) suggest
that the ability of mucins to manage microbial virulence may be a
general mechanism that is present on all mucosal surfaces as part
of the innate mucosal immune system.
FIG 3 Mucins reduce attachment of C. albicans to polystyrene and mucus-
secreting human cells. (A) Fluorescence microscopy images of 96-well poly-
styrene plates after incubation with C. albicans under different medium con-
ditions (RPMI alone or with 0.5% methylcellulose, 0.5% industrially purified
mucin, or 0.5% native mucin). Images were obtained every 15 min, after re-
moval of nonadherent cells. (B) Quantification of attachment to the polysty-
rene plates. Error bars represent standard deviations of the results from 3
replicates. (C) Diagram illustrating the experimental setup of the epithelial
infection assay, and fluorescence and phase-contrast microscopy images of
C. albicans SC5314 stained with calcofluor white after 2 h of incubation with
HT29-MTX human mucus-secreting cells. (D) Quantification of C. albicans
attachment to HT29-MTX cells. Error bars represent standard deviations of
the results from 3 replicates.
Kavanaugh et al.
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Howmight mucins prevent the transition to the hyphal form?
Mucins, but not the other tested polymers, were capable of block-
ing this transition, suggesting that specific, mucin-associated gly-
cans might be involved in this process. Consistent with this idea,
glucose, maltose, and galactose in solution can all influence the
formation of hyphae inC. albicans (34). The identity of themucin
glycan moieties that are recognized by C. albicans, as well as the
receptors and pathways in the yeast that are affected by these sug-
ars, are currently unknown; their identification may suggest new
valuable strategies for preventing or recovering C. albicans infec-
tions of mucosal surfaces.
Preventing biofilm formation on materials exposed to living
organisms presents a vexing engineering challenge; the results ob-
tained for mucus hydrogels may provide some interesting new
strategies. Our experiments show that mucins and methylcellu-
lose are both effective in suppressing C. albicans surface attach-
ment. Both polymers appear to reduce the ability for initial surface
attachment;moreover, they render newly formed cells less capable
FIG 4 Mucins reduce biofilm formation of C. albicans. Biofilms were grown using strain HGFP3 that produces GFP upon transcription from a hyphal-specific
promoter. (A) Macroscopic view of biofilms grown in the presence or absence of mucins or methylcellulose. (B) Fluorescence microscopy images overlaid on
phase-contrast images of C. albicans found in biofilm supernatants. (C) Confocal images of biofilms grown in the presence or absence of mucins. (D and E)
Quantification of biofilm biomass (D) and of C. albicans found in biofilm supernatants (E). RFU, relative fluorescence units. Error bars show SD. P values
indicated by asterisks are0.05.
Mucins Suppress Virulence of Candida albicans
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of stably integrating into an emerging biofilm. How these poly-
mers work to suppress surface attachment and even whether they
function by the same mechanisms are open questions. Despite
their superficial resemblance in surface protection, mucins and
methylcellulose have different effects on the surrounding C. albi-
cans cell population. With methylcellulose, the vast majority of
cells remain in the filamentous form, while a cell population ex-
posed to mucins remains largely devoid of filaments. There is
good experimental evidence that the ability to form filaments is
required for C. albicans virulence (35). Therefore, we have shown
that the native mucins in the body are capable of providing a dual
mechanism for virulence control, suppressing both the yeast-
hyphal transition and surface attachment.
The ability of mucins to suppress virulence traits is not specific
forC. albicans but appears to apply also to a range of other micro-
organisms, including the bacteria Helicobacter pylori and Pseu-
domonas aeruginosa (7, 8) and, also, certain viruses, such as HIV
and influenza virus (10, 11). Understanding themechanism of the
mucin-Candida host-pathogen interaction could direct treatment
strategies for regulating the healthymicrobiota and also shed light
on the molecular origins of increased susceptibility to microbial
disease.
MATERIALS AND METHODS
C. albicans strains andmedia. Strains weremaintained on YPD agar (2%
Bacto peptone, 2% glucose, 1% yeast extract, 2% agar) and grown at 30°C.
Single colonies were inoculated into YPD broth and grown with shaking
overnight at 30°C prior to each experiment.
The experiments were performed using either Gibco RPMI 1640 me-
dium (catalog number 31800-089; Life Technologies) buffered with
165 mM morpholinepropanesulfonic acid (MOPS) and supplemented
with 0.2% NaHCO3 and 2% glucose or YPD medium with 10% fetal
bovine serum (FBS). Medium with 0.5% methylcellulose (15 centipoise
[cP]; Sigma) was prepared from a 5% stock solution by dilution in RPMI.
Type II mucin from porcine stomach (Sigma) was dialyzed in a Spectra/
Por Float-A-Lyzer G2 dialysis tube with a 100-kDamolecularmass cutoff,
followed by lyophilization. Industrial PGM and native PGM were dis-
solved in RPMI and gently vortexed at 4°C overnight.
The C. albicans yeast strains used in this study were SC5314 and
HGFP3. Strain HGFP3 (36) was constructed by inserting the GFP gene
next to the promoter ofHWP1, a gene encoding a hyphal cell wall protein,
and was provided by E.Mylonakis (Massachusetts General Hospital, Bos-
ton, MA) with the permission of P. Sundstrom.
Mucin purification. The mucins were natively purified to preserve
their properties, as opposed to industrially purified mucins which do not
form gels in solution (23, 22). Porcine gastric mucins (PGM) were puri-
fied from fresh pig stomachs as previously described (37). Briefly, the
mucus layer was isolated from pig stomachs and solubilized in sodium
chloride buffer containing protease inhibitors to prevent mucin degrada-
tion and sodium azide to prevent bacterial proliferation. Insoluble com-
ponents were removed via centrifugation, and the mucins were isolated
using gel filtration chromatography on a Sepharose column (CL2B). The
mucins were then concentrated and lyophilized. As a control to ensure
that there were no contaminants in the mucin preparation, mucins pre-
pared by CsCl gradient centrifugation (as described in references 38 and
39) were compared to those prepared without this step.
Extraction of RNA and cDNA synthesis. One milliliter of RPMI or
0.5% PGM in RPMI in a culture tube was inoculated with 10 l of an
overnight culture of strain SC5314 and incubated at 37°C and 180 rpm for
8 h. RNA was extracted using the Epicentre MasterPure yeast RNA puri-
fication kit and treated with Sigma-Aldrich AMPD1 amplification-grade
DNase I. Five hundred nanograms of RNA per sample was used to gener-
ate cDNA using the Invitrogen SuperScript III first-strand synthesis sys-
tem. cDNA samples were stored at80°C until use.
Quantitative PCR. All primers were obtained from Sigma and ana-
lyzed for efficiency before use in experiments. Efficiency was calculated by
performing qPCRwith serial 1:10 dilutions of genomic DNA. Bio-Rad iQ
SYBR green supermix was used for qPCRs. Experiments were performed
in a Roche LightCycler 480 II machine with the following run protocol:
95°C for 3 min and then 40 cycles of 95°C for 10 s, 58°C for 30 s, and 72°C
for 30 s. Cycle threshold (CT) values were obtained and used for analysis.
Fold changes were calculated using the CT method in comparison to
the results for the reference gene TAF145.
Filamentation assay. One hundred microliters each of RPMI, 0.5%
methylcellulosemedium, 0.5% industrial PGMmedium, and 0.5%native
PGMmedium were inoculated with the strain HGFP3 as yeast form cells
or hyphae in a 96-well plate. One microliter of an overnight culture was
used as the source for yeast form cells. For hyphae, an overnight culture
was diluted 1:100 into YPD plus 10% FBS, which stimulates the transition
to hyphae, and grown to an optical density at 600nm (OD600) of 0.5. The
hyphae were centrifuged and then resuspended to an OD600 of 5, and
10-l amounts were added to media under the aforementioned condi-
tions. The cells were incubated at 37°C with shaking at 180 rpm for 8 h.
Adherent cells were scraped off of the surface, and samples were pipetted
vigorously to break up aggregates. A 15-l amount of each sample was
placed on a microscope slide for visualization. Slides were imaged with a
Zeiss Observer Z1 inverted fluorescence microscope with a Zeiss Plan-
Apochromat 20 objective lens using phase-contrast and fluorescein iso-
thiocyanate (FITC) (excitation at 475 nm and emission at 530 nm).
Polystyrene attachment assay. Polystyrene 96-well plates were inoc-
ulated with 100 l of RPMI, 0.5% methylcellulose medium, 0.5% indus-
trial PGMmedium, and 0.5%native PGMmedium containing yeast form
cells from the strain SC5314. The plates were incubated statically at 37°C.
Every 15 min, a time point sample was taken by washing the wells with
200l of phosphate-buffered saline (PBS) twice, followed by the addition
of 100 l of PBS. After 1 h, 1 l of 1 mg/ml calcofluor white solution was
added to each well. The samples were imaged similarly to the description
above using a 10 objective (excitation at 365 nm and emission at 445
nm). The experiment was performed in triplicate with 5 pictures taken of
each well. The images were analyzed in ImageJ as follows: each image was
converted to 8-bit and the contrast was enhanced (0.4% saturated pixels).
The image was then thresholded to create a binary image. The image was
then analyzed using the Analyze Particles tool to measure the surface area
covered by cells. The surface area measurements of the 15 images for each
condition and time point were averaged.
Attachment to human mucus-secreting colorectal cells (HT29-
MTX). HT29-MTX mucus-secreting cells reliably secrete a thick, homo-
geneous layer of mucus as soon as 7 days postconfluence. The cells were
grown in a 24-well plate. At 2 weeks postconfluence, the cells were treated
with 10mMN-acetylcysteine, which cleaves disulfide bonds betweenmu-
cins (40), for 30min to remove the adherent mucus layer or with PBS as a
control. For infection,C. albicans strain SC5314was diluted from an over-
night culture into Dulbecco modified Eagle medium to an OD600 of 0.5.
Five hundred microliters of C. albicans was added on top of the HT29-
MTX cells and incubated statically at 37°C for 2 h. After 2 h, the medium
was removed from the wells, which were subsequently washed twice with
500l of PBS. The remainingC. albicans cells were stainedwith calcofluor
white and analyzed using a Zeiss Observer Z1 inverted fluorescence mi-
croscope and a plate reader (excitation at 355 nm and emission at 460
nm).
TheHT29-MTX cells were derived fromHT-29 cells (ATCCHTB-38)
as described previously (29). HT-29 cells were derived from an anony-
mous donor.
Biofilm formation assay and visualization. Biofilms were grown on
either of two surfaces: in a 96-well plate (formacroscopic views and quan-
tification) or on 8-mm-diameter silicone circles (for confocal imaging).
Before the experiment, the silicone circles were washed with water and
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autoclaved. The surfaces were incubated in adult bovine serum overnight
with shaking at 37°C. The next day, the surfaces were washed in PBS and
submerged in a C. albicans cell suspension with an OD600 of 0.5 in RPMI
with or without 0.5% mucins. The samples were incubated at 37°C with
shaking at 180 rpm for 90 min to facilitate attachment of yeast cells to the
surface. Nonadherent cells were washed away with PBS, and the samples
were subsequently submerged in fresh RPMI with or without 0.5% mu-
cins, 0.5% industrial mucins, or 0.5%methylcellulose. The biofilms were
allowed to growwith shaking (180 rpm) at 37°C for the times indicated in
Fig. 4. For biomass quantification, the biofilms were stained with
20g/ml calcofluorwhite in PBS for 10min and analyzed in a SpectraMax
M3 plate reader (excitation at 355 nm and emission at 460 nm). Biofilm
supernatant quantification was performed in the same plate reader (ab-
sorbance at 600 nm). For confocal imaging, the biofilms were submerged
in 6 ml of 20 g/ml calcofluor white and stained for 10 min. The biofilms
were imaged using a photo scanner or a Zeiss LSM 700 upright confocal
microscope. Planktonic cells were placed on microscope slides and im-
aged using a Zeiss wide-field fluorescence microscope.
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